Replies to post #34412 on Intellipharmaceutics International Inc. (IPCI)

[fabius]

Impact, hope you can explain Odidi that he has been driving us against a wall.

I tell you this; if we get delisted from NASDAQ, likely Armistice, Anson and Sabby will dump...we go to 0.10$...then we stay in the Toronto Stock Exchange (and maybe OTC);

but we are not going back to 3$ (or the equivalent in CAD).

Nobody will never ever put faith in Odidi, capable to consistently destroy value although having an appealing pipeline.

Reputation and track record are gonna kill us

[doogdilinger]

The problem with IPCI mgmt. is they're terrible at conveying their story to market and do absolutely nothing to change how the market perceives them and this company.

They have collectively driven the once great potential of their pipeline into the ground, and with each passing quarter they never show any positive progress.

Instead they continue to allow time to pass them by without getting off their collective butts and proving to market that they can in fact advance their now totally stagnated pipeline.

So when CFO Patient tells you or anyone else to just be patient, it definitely falls on deaf ears as well it should...especially since IPCI mgmt. continues to prove by their ongoing actions/inactions completely inept and incapable of unlocking a single shred of the once great potential inherent value of IPCI's stagnant pipeline.

Where's the PODRAS POC trials in humans for example?

And where's the CAT 2 & 3 oral and nasal HAP studies?

Both of those key material advancements have been completely stagnant since last summer and with each passing quarter mgmt. never bothers conveying any progress to market to show how they're even planning on advancing either key material development in a positive direction.

And don't even get me started on the bonuses they continue to award themselves for ANDA's that aren't adding a shred of inherent value to their still evolving equation. At the very least they should forego their ANDA bonuses unless and until FDA approvals actually translate to measurable value being added to their books. As it stands right now though they continue to remain completely oblivious to this glaring red flag and continue to reward themselves for the piss poor blood sucking mess their entire generics pipeline has turned into.

Dr. Odidi gallivanting around Shanghai and wanting to add a new board member to facilitate his ongoing China endeavors when he hasn't done 1 thing in China yet that directly benefits IPCI's market is only the latest in a long line of never ending piss poor decisions that continue to fuel the much deserved market apathy that plagues this stock...and I honestly can't believe how blind mgmt. has become to the negative market messaging they continue to fuel...when they alone control their storyline and direction and have the power to completely revamp and overhaul what they're doing and how they're presenting their ongoing story to market.

[tilator]

I will be having dinner with Dr Odidi in a week. He fully knows my position and has agreed to go to dinner. That’s not a man who is hiding from shareholders. Patient immediately called me back yesterday afternoon before I boarded the plane. He still seems optimistic.

This scares me most. I've seen this before. They know they need someone to tell nice things to other shareholders.

[mopar44o]

Well I've sent 2 emails and left messages on both his work and cell and not getting any calls back.